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within the same time frame. In each group, there were four 
men and two women, ranging in age from 16 to 59 years 
(mean 35). Group I consisted of six patients who presented 
with sudden unexpected cardiovascular collapse, apparently 
in association with cardiac asystole, of sufficient duration to 
result in initiation of resuscitative measures. Group II in- 
cluded six patients with a history compatible with recurrent 
but self-limited neurally mediated syncope (for example, 
vasovagal syncope) without evident asystole and in whom 
conventional electrophysiologic evaluation failed to detect 
an abnormality of sufficient magnitude to account for syn- 
cope. Group III consisted of six patients with recurrent 
syncope in whom positive findings during conventional 
electrophysiologic testing provided a basis for the syncopal 
symptoms. None of these patients had been taking cardio- 
active medication at the time of syncope. 
For purposes of this study, an asystolic pause was defined 
as absence of perceptible pulse or ECG documentation of 
cardiac asystole, or both, for an interval 2 12 s, accompanied 
by loss of consciousness and postural tone. 
Diagnostic evaluation. All patients provided a complete 
medical history and underwent physical examination and 
routine laboratory testing. Vital signs were recorded in all 
patients, and individual right and left carotid sinus massage 
was performed during continuous ECG monitoring. M-mode 
and two-dimensional echocardiography as well as neurologic 
consultation was obtained in all patients. 
Electrophysiologic study. After informed consent was ob- 
tained, all patients underwent invasive electrophysiologic 
evaluation in the postabsortive state using mild sedation 
(diazepam, 5 mg intravenously). All cardioactive medica- 
tions were discontinued for at least five half-lives before 
electrophysiologic study. Three 6F quadripolar electrode 
catheters were inserted into the right femoral vein, using the 
percutaneous approach and modified Seldinger technique, 
and positioned at the high right atrium, at the right ventric- 
ular apex and across the tricuspid valve for His bundle 
recording, respectively. An intraarterial cannula was placed 
percutaneously into the femoral artery to monitor arterial 
pressure. Surface ECG leads I, II, III, V, and V,; intracar- 
diac recordings from the high right atrium, right ventricle 
and His bundle position along with arterial blood pressure 
were simultaneously displayed on an Electronics for Medi- 
cine VR16 recorder and recorded simultaneously on fre- 
quency modulation tape. Recordings were obtained at a 
speed of 50 or 100 mm/s. Pacing was accomplished by means 
of a custom-designed programmable stimulator with opti- 
cally isolated outputs. The stimulus duration was 2 ms, and 
the amplitude was twice diastolic threshold. 
Baseline sinus cycle length and conduction intervals were 
recorded. Sinus node function was assessed by determining 
sinus node recovery time at a pacing cycle length ranging 
from 300 to 700 ms at 50 ms decrements. The subsequent 10 
postpacing intervals were analyzed for the presence of 
secondary pauses. Atrioventricular node and infranodal con- 
duction and refractoriness characteristics were determined 
both by right atria1 pacing at progressively shorter cycle 
lengths and by extrastimulus testing using a drive train of 
eight cycles at a basic pacing length of 600 and 400 ms. Single 
atria1 extrastimuli were introduced at 10 ms decrements until 
refractoriness was reached. 
The protocol for ventriculur electrical stimulation in- 
cluded scanning of diastole with single, double and triple 
ventricular extrastimuli introduced after an eight beat ven- 
tricular drive train, utilizing a basic pacing cycle length of 
600 and 400 ms. Ventricular extrastimulus testing was per- 
formed at both the right ventricular apex and outflow tract. 
The extrastimuli coupling intervals were progressively short- 
ened by 10 ms until ventricular refractoriness was reached. 
Upright tilt. After conventional electrophysiologic test- 
ing was completed, baseline measurements of heart rate and 
blood pressure were recorded with the patient in the supine 
position. Using an electronically controlled tilt table with a 
foot board for weight bearing, upright tilt (80” head-up) (4,5) 
was then performed for up to IO min, with a positive 
response being defined as development of syncope. If the 
patient did not have a positive response during baseline 
conditions, he or she was lowered to the supine position at 
the end of the 10 min period. After a rest period of 5 min, 
upright tilt was repeated during continuous intravenous 
isoproterenol infusion at successive incremental doses of 1 
and, if necessary, 3 pg/min. During each step of the proto- 
col, the patient was returned to the supine position either 
when a positive response was achieved or after 10 min of 
upright tilt. An equilibration period of 5 min, during which 
heart rate and blood pressure were allowed to achieve a 
stable baseline value, was introduced between each succes- 
sive increase in isoproterenol dose. 
Statistical analysis. Group data are reported as mean 
values i SD. lntergroup comparisons were made using 
Student’s t test. with a p value ~0.05 being considered 
indicative of a statistically significant difference. 
Results 
Clinical and Electrophysiologic Findings 
Group I: patients presenting with cardiovascular collapse 
and apparent asystole. Patient 1 had recurrent episodes of 
syncope associated with hypotension-bradycardia syn- 
drome. During one of the episodes, his wife (a trained 
intensive care unit nurse) was unable to detect any pulse for 
a 20 s period. The patient recovered after cardiopulmonary 
resuscitation was initiated. Patient 2 had a history of recur- 
rent syncope and presented with cardiovascular collapse, 
during which 22 s of cardiac asystole was fortuitously 
documented by ambulatory ECG monitoring. Patient 3 was a 
well trained athlete who collapsed while running. A cardiol- 
ogist witnessing the scene initiated cardiopulmonary resus- 
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Figure 1. Changes in mean arterial pressure (left 
panel) and heart rate (right panel), comparing 
measurements at 1 min after assumption of up- 
right posture with those at the time of syncope in 
six Group I patients with cardiovascular collapse 
and apparent asystole. Mean arterial pressure 
decreased from 70 to 24 mm Hg, and the chrono- 
tropic response was inadequate in five patients 
with a decrease in heart rate from 97 to 55 
beats/mitt. Circles = tilt alone; triangles = tilt 
plus isoproterenol infusion at 1 pg/min; squares = 
tilt t isoproterenol infusion at 3 pg/min. - 
TILT SYNCOPE TILT SYNCOPE 
1 min 1 min 
ASYSTOLIC 
citation after confirming that the patient had no pulse and 
was apneic. Patient 4, a competitive swimmer, sustained a 
cardiac arrest while swimming strenuously and dropped to 
the bottom of the swimming pool. After rescue, cardiopul- 
monary resuscitation was initiated after it was confirmed 
that she had no pulse and was apneic. Patient 5 was a 
medical resident who was running to an emergency call 
when he suddenly collapsed. Cardiac asystole was docu- 
mented by ECG and he recovered after a period of cardio- 
pulmonary resuscitation. Patient 6 had a history of recurrent 
syncopal events and presented after an episode of cardio- 
vascular collapse, during which 15 s of asystole was docu- 
mented in a hospital emergency room. 
Five of these six patients had no evidence of underlying 
structural heart disease on the basis of history, ECG and 
M-mode and two-dimensional echocardiography. Patient 6 
had a past history of an uncomplicated acute anterior myo- 
cardial infarction 13 years before the first syncopal event. All 
six patients had normal findings on electrophysiologic eval- 
uation. 
Group II: patients with syncope and normal conventional 
electrophysiologic study. This group of six patients had no 
structural heart disease and had normal electrophysiologic 
evaluation. They underwent tilt evaluation according to a 
protocol for patients with recurrent unexplained syncope. 
Group III: patients with syncope and diagnostic conven- 
tional electrophysiologic study. Two of the six patients had 
pre-excitation syndrome, two had coronary artery disease, 
one had nonischemic cardiomyopathy and one had no evi- 
dence of structural heart disease. Electrophysiologic find- 
ings that appeared to indicate the cause of syncope were 
orthodromic reciprocating tachycardia with marked hypo- 
tension in one patient, atria1 fibrillation with rapid ventricu- 
lar response and associated hypotension in two patients, 
infra-His bundle block associated with a long HV interval 
and bifascicular bundle branch block in one patient and 
inducible polymorphic ventricular tachycardia in two pa- 
tients. 
Response to Upright Tilt 
Group I: patients presenting with cardiovascular collapse 
and apparent asystole. All six patients presenting with ap- 
parent asystolic cardiovascular collapse developed syncope 
during upright tilt provocation. In each case, compared with 
a baseline mean arterial pressure measured 1 min after 
assumption of upright posture, syncope was associated with 
a marked decrease in mean arterial pressure (from 70 ? 8 
mm Hg at 1 min of tilt to 24 f 6 mm Hg at the time of 
syncope, p < 0.001) ( Fig. 1). The chronotropic response to 
this degree of hypotension was inadequate and directionally 
inappropriate in five of the six patients, decreasing from 90 + 
33 beats/min at 1 min of tilt to 39 2 19 beats/min during the 
syncopal spell (Fig. 2). Two patients (Cases 2 and 5) mani- 
fested 16 and 20 s of asystole, respectively (Fig. 2). One 
patient (Case 3) exhibited a positive chronotropic response 
during tilt provocation, but nonetheless became markedly 
hypotensive and syncopal. 
Three patients (Cases 1,4 and 6) became syncopal during 
tilt alone (at 4,3 and 2 min of tilt, respectively). Two patients 
(Cases 2 and 3) tolerated tilt in the baseline state, but 
exhibited syncope when tilt was performed during isoproter- 
enol infusion at 1 pg/min. The latter patients became synco- 
pal at 5 and 2 min of tilt, respectively. One patient (Case 5) 
tolerated baseline upright tilt and tilt during isoproterenol 
infusion at 1 pg/min, but developed syncope at 2 min during 
combined tilt and isoproterenol infusion at 3 pg/min. 
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Group II: patients with syncope and negative conventional 
electrophysiologic study. All six patients with a history sug- 
gestive of self-limited neurally mediated syncope and nega- 
tive conventional electrophysiologic test results manifested 
syncope in <5 min during upright tilt. Three had syncope 
during upright tilt alone, and three during upright tilt in 
conjunction with intravenous isoproterenol infusion at 1 
pg/min. These patients exhibited a substantial decrease in 
mean arterial pressure (from 71 k 7 mm Hg at 1 min of tilt to 
31 t 3 mm Hg at the time of syncope, p = 0.002) with 
concomitant inadequate and directionally inappropriate 
heart rate response (from 102 * 10 beats/min at 1 min of tilt 
to 54 ? 13 beatsimin at time of syncope, p = O.OOl), (Fig. 3). 
Group III: patients with syncope and diagnostic conven- 
tional electrophysiologic study. None of the six patients in 
this group experienced syncope during upright tilt during 
either baseline conditions or continuous intravenous isopro- 
Figure 2. Patient 2, Group I. Continuous recording of an induced 
asystolic event. At 2 min of upright tilt, the arterial blood pressure 
(BP) is 1401100 mm Hg and heart rate is 94 beats/min. With a 
progressive decrease in arterial pressure to 120180 mm Hg the heart 
rate is approximately 82 beatsimin (top panel). With a steady 
decrease in arterial pressure, the heart rate slows up to the point 
when with an arterial pressure of 80140 mm Hg, the patient became 
asystolic (second panel). Asystole lasted for 16 s during which the 
patient was returned to the supine position. After a few seconds in 
the supine position, there is a junctional escape beat (bottom panel) 
and subsequently after a pause of 4 s, sinus rhythm resumes (third 
panel). HB = His bundle electrogram; L2 = lead II of the electro- 
cardiogram: RV = right ventricular electrogram. 
terenol infusion at 1 and 3 pg/min. Comparing mean arterial 
pressure and heart rate at 1 min of upright tilt with values at 
the last minute of tilt (10 min), there was a moderate but 
consistent decrease in blood pressure (85 + 4 versus 71 c 3 
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mm Hg) with a directionally appropriate chronotropic re- 
sponse (121 ? 7 versus 133 ? 7 beats/min) (Fig. 4). 
Intergroup comparison of tilt response. Maximal changes 
in mean arterial pressure and heart rate from values at 1 min 
of upright tilt to the moment of syncope in patients in Groups 
I and II and from the 1st to the 10th min of upright tilt in 
patients in Group III differed dramatically (Fig. 5). Patients 
in Groups I and II experienced marked hypotension- 
bradycardia; mean arterial pressure decreased 46 ? 9 and 40 
+ 9 mm Hg and heart rate decreased 44 ? 28 and 49 ? 12 
beats/min in Group I and Group II, respectively. Con- 
versely, patients in Group III exhibited only a moderate 
decrease in arterial pressure (14 ? 5 mm Hg) in conjunction 
with an increase in heart rate (14 ? 8 beatslmin). 
The difference in maximal mean arterial pressure and 
Figure 3. Changes in mean arterial pressure (left panel) 
and heart rate (right panel), comparing measurements 
from 1 min after assumption of upright posture with 
those at the time of syncope in six Group II patients 
with syncope and normal findings on electrophysio- 
logic (EP) evaluation. There is a marked decrease in 
mean arterial pressure from 71 to 31 mm Hg. The 
chronotropic response to this degree of hypotension is 
inadequate, and the heart rate decreases from 102 to 54 
beatslmin. Symbols as in Figure 1. 
heart rate changes during upright tilt between Group I and 
Group II patients was not statistically significant. However, 
both mean arterial pressure and heart rate changes during 
upright tilt differed significantly (p < 0.001) in Group I and 
Group III patients. 
Discussion 
Tilt-induced hypotension-hradycardia in patients with syn- 
cope. This study demonstrates that patients with suspected 
or documented cardiac asystole and normal conventional 
electrophysiologic evaluation exhibit a susceptibility to tilt- 
induced neurally mediated hypotension-bradycardia. In- 
deed, on occasion, head-up tilt resulted in a prolonged 
asystolic event. Furthermore, electrophysiologic and tilt 
140 -- s 60-- 1 / 1 
‘E 
120 -- 
IF 
Figure 4. Changes in mean arterial pressure (left 
L 1 panel) and heart rate (right panel), comparing 
L 
2 60-- E 
100 -- measurements at 1 min after assumption of up 
right posture with those at 10 min of upright 
t3 
e 
80 -- 
g E 
posture in the six Group III patients with syncope 
2 
and diagnostic electrophysiologic (EP) evalua- 
6 40 -- s 60 -- tion. During continuous isoproterenol infusion at 
5 
I 3 pg/min, there is a moderate but consistent 
3 40 -- decrease in mean arterial pressure from 85 to 71 
I 2o-- mm Hg. The chronotropic response to this degree 
20 -- of hipotension is adequate, and the heart rate p-0.c.X p-0.ocU increases from 121 to 133 beats/mitt. Symbols as 
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Figure 5. Summary of maximal changes 
in mean arterial pressure (left panel) and 
heart rate (right panel) associated with 
upright tilt in Groups III, II and I (EP 
positive, EP negative and asystolic, re- 
spectively). Mean arterial pressure de- 
creased dramatically in Group I and 
Group II patients, whereas it decreased 
only moderately in Group III patients. 
Concomitantly, patients in Group III had 
an increase in heart rate, whereas the 
other two groups of patients had a 
marked decrease in heart rate. The dif- 
ference in maximal changes in mean ar- 
terial pressure and heart rate comparing 
patients in Group III with patients in 
Groups I and II is statistically significant. 
However, the difference in maximal 
mean arterial pressure and heart rate 
changes between patients in Group I and 
Group II is not statistically significant. 
20 
0 
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-60 p(O.001 
-60 
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table findings in patients presenting with apparent asystolic 
cardiovascular collapse are essentially identical to those 
observed in individuals with more conventional forms of 
self-limited recurrent neurally mediated syncope, but differ 
substantially from findings in patients with syncope related 
to other demonstrable cardiac electrophysiologic abnormal- 
ities. Accordingly, both cardiovascular collapse associated 
with prolonged cardiac asystole and syncope of neurally 
mediated origin may be elements of the spectrum of hypo- 
tension-bradycardia syndrome in humans, a concept first 
alluded to by Engel (3): “When a person collapses but 
quickly recovers, it is called fainting or syncope. When he 
dies within the next few minutes, it is called sudden or 
instantaneous death.” 
Catecholamines and neurally mediated hypotension- 
bradycardia in humans. Bradyarrhythmias are an uncom- 
mon but recognized cause of cardiovascular collapse and 
sudden cardiac death (1,2). Despite the difficulty of docu- 
menting such episodes, several reports (6-10) have substan- 
tiated the occurrence of cardiac asystole during exertion as a 
cause of cardiovascular collapse. Studies (11,12) in patients 
with inducible vasovagal reactions have demonstrated in- 
creases in heart rate before development of syncopal symp- 
toms that are suggestive of a transient premonitory incre- 
ment in adrenergic tone. In fact, in some patients, elevation 
of circulating catecholamines has been observed before the 
development of syncope (13). The occurrence of the clinical 
asystolic event during exercise in three of our six Group I 
patients is supportive of the importance of a preceding 
increment in catecholamine levels and is consistent with 
previous reports (14) of hypotension and bradycardia in 
young asymptomatic volunteers performing treadmill exer- 
cise. 
EP 
NEGATIVE 
ASYSTOLIC 
p - 0.005 1 p - “8 
I 
EP EP ASYSTOLIC 
POSITIVE NEGATIVE 
The role played by a transient catecholamine elevation in 
increasing susceptibility to or even triggering an episode of 
hypotension and bradycardia is uncertain. Conceivably, a 
predominant beta,-adrenergic agonist effect might account 
for vasodilation and hypotension, but it cannot explain the 
marked bradycardia observed in our patients. In contrast, a 
catecholamine-induced enhanced myocardial contractile 
state, particularly in the setting of a relative diminution of 
central volume, may initiate neural reflex activity. resulting 
in both hypotension and bradycardia. 
It has been proposed (15,16) that ventricular mechanore- 
ceptors may play an important role in initiating the reflex 
responses associated with hypotension-bradycardia. Under 
normal conditions, venous pooling associated with upright 
posture is compensated for by both reflex tachycardia and 
venous and arteriolar constriction. Under conditions of 
reduced venous return, cardiac mechanoreceptors normally 
exhibit diminished activity, thereby promoting reflex sym- 
pathetic stimulation. However, experimental evidence 
(15.16) suggests that rapid loss of central volume in conjunc- 
tion with the excitatory effects of increased circulating 
catecholamines (such as may occur during hemorrhage) can 
result in vigorous left ventricular contraction with conse- 
quent increased afferent neural traffic (15). provoking both 
bradycardia and vasodilation (16). 
Clinical implications. Findings in this study suggest that 
asystole and cardiovascular collapse may occur in certain 
individuals on a neurally mediated basis. Furthermore, elec- 
trophysiologic and hemodynamic findings during provoca- 
tive tilt testing are indistinguishable in these patients com- 
pared with others presenting with self-limited syncope of 
neurally mediated origin (4.5,17-22) and are markedly dif- 
ferent from findings in control subjects. The latter only 
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infrequently exhibit unanticipated hypotension-bradycardia 
when undergoing the tilt test protocol described here (4). 
Because cardiac asystole may be a manifestation of 
neurally mediated hypotension-bradycardia syndrome, this 
possibility should be considered when studying survivors of 
sudden death. Immediate identification of these patients 
poses a management dilemma. At first, it may seem reason- 
able to consider permanent pacemaker implantation in indi- 
viduals with recurrent neurally mediated syncopal episodes 
in an attempt to avert the potential fatality related to this 
syndrome. However, as demonstrated by Almquist et al. 
(23), maintenance of heart rate does not necessarily reverse 
hypotension in association with the vasodepressor response 
despite preventing the bradycardia. In fact, Patients 2 and 6 
in the asystolic group of patients (Group I), in the present 
study continued having syncope despite implantation of a 
permanent pacemaker (before referral for study). 
Recent preliminary reports from this laboratory (24,25) 
suggest that beta-adrenergic blocking agents or drugs with 
combined anticholinergic and negative inotropic effects 
(such as disopyramide) may be useful in preventing tilt- 
induced hypotension-bradycardia and recurrent syncope. It 
seems reasonable to postulate that this therapeutic approach 
might be beneficial in patients with cardiac asystole, normal 
findings on electrophysiologic evaluation and tilt-induced 
hypotension-bradycardia. However, careful clinical studies 
are essential before such a treatment strategy can be recom- 
mended. 
We are indebted to the staff of the Cardiac Catheterization Laboratory for 
their assistance and to Wendy Markuson for assistance in the preparation of 
the manuscript. 
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